SI
INSM icon

Sofinnova Investments’s Insmed INSM Stock Holding History

Sofinnova Investments’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100,000
Closed -$2.71M – 85
2024
Q1 		$2.71M Buy
+100,000
New +$2.8M 0.15% 55

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Sofinnova Investments's INSM Position: Q2 2026 in Review

Sofinnova Investments reduced its Insmed (INSM) stake by 54% in Q2 2026, selling an estimated $22.7M and leaving 158,398 shares worth $16.9M. The position accounts for 0.87% of the portfolio, ranked #29.

Sofinnova Investments first reported a position in INSM in Q1 2019 and has held it in 20 quarters since. The position peaked at $56.6M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Sofinnova Investments held 158,398 shares of Insmed worth $16.9M as of Q2 2026.
  • Sofinnova Investments sold 187,677 Insmed shares in Q2 2026, an estimated $22.7M.
  • Insmed made up 0.87% of Sofinnova Investments's portfolio in Q2 2026, its #29 holding.
  • Sofinnova Investments first reported a position in Insmed in Q1 2019 and has held it in 20 quarters since.
  • Sofinnova Investments's Insmed position peaked at $56.6M in Q1 2026.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Sofinnova Investments's 13F filing for Q2 2026, filed 14 Aug 2026.